Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior
Min Eui Hong(Jiangsu T-mab BioPharma (China)), Young Hyeh Ko(Cheju Halla General Hospital), So Young Kang(Ajou University), Suk-Jin Kim(Duksung Women's University), Taehee Lee(Samsung Medical Center), Won-Seog Kim(Samsung Medical Center)
Cited by 53
Related Papers
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
|New England Journal of Medicine|2022|342
Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
|Journal of Clinical Oncology|2019|154
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
|The Lancet Oncology|2009|120
NTRK1 Fusion in Glioblastoma Multiforme
|PLoS ONE|2014|97